JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+2.5%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$180M
AUM Growth
+$180M
(+57%)
Cap. Flow
+$70M
Cap. Flow
% of AUM
38.88%
Top 10 Holdings %
Top 10 Hldgs %
84.18%
Holding
72
New
18
Increased
38
Reduced
4
Closed
8
Top Buys
| 1 |
Mercado Libre
MELI
|
$34.4M |
| 2 |
Wells Fargo
WFC
|
$20.2M |
| 3 |
StoneCo
STNE
|
$16.2M |
| 4 |
Afya
AFYA
|
$7.96M |
| 5 |
PagSeguro Digital
PAGS
|
$5.26M |
Top Sells
| 1 |
Vale
VALE
|
$15M |
| 2 |
Meta Platforms (Facebook)
META
|
$8.44M |
| 3 |
LINX
Linx S.A.
LINX
|
$5.84M |
| 4 |
Galicia Financial Group
GGAL
|
$2.66M |
| 5 |
Banco Macro
BMA
|
$542K |
Sector Composition
| 1 | Consumer Discretionary | 31.59% |
| 2 | Technology | 23.03% |
| 3 | Financials | 12.43% |
| 4 | Healthcare | 11.38% |
| 5 | Consumer Staples | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
26
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $684K | 0.38% |
5,585
+1,220
| +28% | +$149K |
|
27
Alphabet (Google) Class C
GOOG
$2.58T
| $610K | 0.34% |
+500
| New | +$610K |
|
28
Mondelez International
MDLZ
$79.5B
| $589K | 0.33% |
+10,648
| New | +$589K |
|
29
Elevance Health
ELV
$71.8B
| $587K | 0.32% |
2,446
+47
| +2% | +$11.3K |
|
30
Pfizer
PFE
$141B
| $576K | 0.32% |
16,030
+310
| +2% | +$11.1K |
|
31
CSX Corp
CSX
$60.6B
| $548K | 0.3% |
+7,907
| New | +$548K |
|
32
Danaher
DHR
$147B
| $537K | 0.3% |
3,718
+74
| +2% | +$10.7K |
|
33
Agilent Technologies
A
$35.7B
| $524K | 0.29% |
6,838
+134
| +2% | +$10.3K |
|
|
SAGE
34
DELISTED
Sage Therapeutics
SAGE
| $505K | 0.28% |
3,601
+71
| +2% | +$9.96K |
|
35
iShares Russell 1000 Value ETF
IWD
$63.5B
| $502K | 0.28% |
+3,913
| New | +$502K |
|
36
Cigna
CI
$80.3B
| $500K | 0.28% |
3,294
+65
| +2% | +$9.87K |
|
|
37
Meta Platforms (Facebook)
META
$1.86T
| $463K | 0.26% |
2,600
-47,400
| -95% | -$8.44M |
|
38
Norfolk Southern
NSC
$62.8B
| $453K | 0.25% |
+2,520
| New | +$453K |
|
39
Eli Lilly
LLY
$657B
| $451K | 0.25% |
4,036
+79
| +2% | +$8.83K |
|
40
HCA Healthcare
HCA
$94.5B
| $408K | 0.23% |
3,387
+67
| +2% | +$8.07K |
|
41
Labcorp
LH
$23.1B
| $389K | 0.22% |
+2,317
| New | +$389K |
|
|
AMRN
42
Amarin Corp
AMRN
$311M
| $378K | 0.21% |
24,915
+4,490
| +22% | +$68.1K |
|
43
Fair Isaac
FICO
$36.5B
| $374K | 0.21% |
+1,231
| New | +$374K |
|
44
BioMarin Pharmaceuticals
BMRN
$11.2B
| $369K | 0.2% |
5,478
+809
| +17% | +$54.5K |
|
45
Merck
MRK
$210B
| $349K | 0.19% |
4,148
+81
| +2% | +$6.82K |
|
46
AstraZeneca
AZN
$248B
| $338K | 0.19% |
7,585
+153
| +2% | +$6.82K |
|
47
Ascendis Pharma
ASND
$11.8B
| $324K | 0.18% |
3,360
+379
| +13% | +$36.5K |
|
48
Hologic
HOLX
$14.9B
| $306K | 0.17% |
6,059
+118
| +2% | +$5.96K |
|
49
Humana
HUM
$36.5B
| $292K | 0.16% |
1,141
+22
| +2% | +$5.63K |
|
|
GHDX
50
DELISTED
Genomic Health, Inc.
GHDX
| $289K | 0.16% |
+4,266
| New | +$289K |
|